Pediatric combined formulation DTaP-IPV/Hib vaccine (Q37524018)

20 August 2017

1 reference

title

Pediatric combined formulation DTaP-IPV/Hib vaccine (English)

1 reference

20 August 2017

2

Scott A Halperin

1 reference

20 August 2017

Craig White

1

1 reference

20 August 2017

David W Scheifele

series ordinal

3

1 reference

20 August 2017

publication date

1 July 2009

1 reference

Expert Review of Vaccines

20 August 2017

published in

1 reference

20 August 2017

volume

8

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

831-840

1 reference

Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned

20 August 2017

cites work

1 reference

Implications of the diphtheria epidemic in the Former Soviet Union for immunization programs

21 January 2018

1 reference

21 January 2018

1 reference

Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003.

21 January 2018

1 reference

Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity

21 January 2018

1 reference

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

21 January 2018

1 reference

Controlled study of a new five-component acellular pertussis vaccine in adults and young children

21 January 2018

1 reference

Pertussis: review of epidemiology, diagnosis, management and prevention.

21 January 2018

1 reference

Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001

21 January 2018

1 reference

Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry

21 January 2018

1 reference

Use of combination vaccines is associated with improved coverage rates

21 January 2018

1 reference

Acellular pertussis vaccines for adolescents

21 January 2018

1 reference

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

21 January 2018

1 reference

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

Immunogenicity of a five-component acellular pertussis vaccine in infants and young children

21 January 2018

1 reference

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children

21 January 2018

1 reference

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

21 January 2018

1 reference

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants

21 January 2018

1 reference

An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants

21 January 2018

1 reference

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

21 January 2018

1 reference

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vacci

21 January 2018

1 reference

Ongoing Control of Haemophilus influenzae Type B Infections in Canadian Children, 2004–2007

21 January 2018

1 reference

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

21 January 2018

1 reference

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.59

1 reference

20 August 2017

1 reference